Komori
Tokai Senko K.K. (3577) · FactDecrease in R&D expenses and stable headcount

R&D activity expenses: ¥45 million

First written in FY2021-Q3. 2 of 15 entries say "Advanced", first in FY2022. Latest entry: FY2026.

15entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2021-Q3 – FY2022-Q3OtherFY2023-Q1 – FY2024-Q3AdvancedFY2024OtherFY2025 – FY20262021: 320212022: 420222023: 420232024: 220242025: 120252026: 12026
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 44 companies write about · 18 as a headwind · 10 as a tailwind

26 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 44 companies compared. The sentences above are computed from all 44.
Full recordFilings, disclosures and news, newest first
  1. FY2026Decrease in R&D expenses and stable headcountAnnual report

    「The Group's total research and development expenses for the fiscal year amounted to ¥46 million, and the Group had 15 research and development staff members.」

    R&D expenses decreased from ¥56 million in the previous fiscal year to ¥46 million, while the number of R&D staff remained at 15, unchanged from the previous fiscal year.
  2. FY2025Increase in R&D expenses and decrease in R&D staffAnnual report

    「The Group's total research and development expenses for the fiscal year amounted to ¥56 million, and the Group had 15 research and development staff members.」

    Full-year R&D expenses changed from ¥55 million to ¥56 million, while the number of R&D staff changed from 20 to 15.
  3. FY2024AdvancedAnnual report

    「The Group's total research and development expenses for the fiscal year amounted to ¥55 million, and the Group had 20 research and development staff members.」

    Full-year R&D expenses changed from ¥43 million to ¥55 million, while the number of R&D staff remained at 20.
  4. FY2024-Q3Disclosure of research and development expenses for the cumulative third quarterAnnual report

    「The Group's total research and development activities amounted to ¥44 million during the nine months ended the third quarter.」

    The Company disclosed research and development expenses of ¥44 million for the nine months ended the third quarter.
  5. FY2024-Q2Disclosure of R&D expenses for the six months ended the second quarterAnnual report

    「The Group's total research and development activities amounted to ¥27 million during the six months ended the second quarter.」

    The Company disclosed research and development expenses of ¥27 million for the six months ended the second quarter.
  6. FY2024-Q1First-quarter R&D expenditure disclosedAnnual report

    「The Group's total research and development activities amounted to ¥14 million during the three months ended the first quarter.」

    The Company disclosed research and development expenses of ¥14 million for the three months ended the first quarter.
  7. FY2023Decrease in R&D expenses and increase in R&D staffAnnual report

    「The Group's total research and development expenses for the fiscal year amounted to ¥43 million, and the Group had 20 research and development staff members.」

    Full-year R&D expenses changed from ¥54 million to ¥43 million, while the number of R&D staff changed from 16 to 20.
  8. FY2023-Q3Disclosure of research and development expenses for the cumulative third quarterAnnual report

    「The Group's total research and development activities amounted to ¥35 million during the nine months ended the third quarter.」

    The Company disclosed research and development expenses of ¥35 million for the nine months ended the third quarter.
  9. FY2023-Q2Disclosure of R&D expenses for the six months ended the second quarterAnnual report

    「The Group's total research and development activities amounted to ¥22 million during the six months ended the second quarter.」

    The Company disclosed research and development expenses of ¥22 million for the six months ended the second quarter.
  10. FY2023-Q1First-quarter R&D expenditure disclosedAnnual report

    「The Group's total research and development expenditure for the cumulative consolidated first-quarter period was ¥12 million.」

    The Company disclosed R&D expenses of ¥12 million for the three months ended the first quarter.
  11. FY2022AdvancedAnnual report

    「The Group's total research and development expenses for the fiscal year amounted to ¥54 million, and the Group had 16 research and development staff members.」

    The Company disclosed full-year R&D expenses of ¥54 million and 16 R&D staff members.
  12. FY2022-Q3Disclosure of research and development expenses for the cumulative third quarterAnnual report

    「The Group's total research and development activities amounted to ¥43 million during the nine months ended the third quarter.」

    The Company disclosed research and development expenses of ¥43 million for the nine months ended the third quarter.
  13. FY2022-Q2Disclosure of R&D expenses for the six months ended the second quarterAnnual report

    「The Group's total research and development activities amounted to ¥30 million during the six months ended the second quarter.」

    The Company disclosed research and development expenses of ¥30 million for the six months ended the second quarter.
  14. FY2022-Q1Disclosure of quarterly R&D expensesAnnual report

    「The Group's total research and development activities amounted to ¥16 million during the three months ended the first quarter.」

    The Company disclosed research and development expenses of ¥16 million for the three months ended the first quarter.
  15. FY2021-Q3First statedAnnual report

    「The Group's total research and development activities amounted to ¥45 million during the nine months ended the third quarter.」

    The Company disclosed total Group research and development expenses of ¥45 million for the nine months ended the third quarter.
Moved together

"Shareholdings held to strengthen business relationships between companies" moved the same way as this thread, in the same document, in 2 of its 15 moves.

22222★12345
  1. ★This thread
  2. 1Shareholdings held to strengthen business relationships between companies2×
  3. 2Launch of a Laundry Business and Expansion in Japan and Overseas2×
  4. 3Review of the domestic dyeing and finishing business structure and preparations for reorganization2×
  5. 4Cost Reduction and Production Efficiency2×
  6. 5Reducing Dependence on Heavy Fuel Oil Through Biomass Utilization2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tokai Senko K.K. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D activity expenses: ¥45 million | Tokai Senko K.K. (3577) | Komori